Literature DB >> 6318205

CCK-8 modulation of mesolimbic dopamine: antagonism of amphetamine-stimulated behaviors.

L H Schneider, J E Alpert, S D Iversen.   

Abstract

Rats (N = 15) were implanted with cannulae above the dopaminergic A10 ventral tegmental area (VTA). Two weeks later, four measures of open field behavior were quantified for 10 minutes commencing 30 minutes after parenteral d-amphetamine (1.5 mg/kg) and directly after bilateral infusion of 1.5 microliter of: (a) artificial CSF only (VEH), (b) 1.25 microgram desulfated CCK (DS-CCK), or (c) 1.25 microgram sulfated CCK (CCK). Additional rats with bilateral cannulae directed toward the A10 terminal zones of nucleus accumbens were similarly tested with either VEH (N = 2) or sulfated CCK (N = 2). With VTA infusions, both the number of occurrences and duration of rearing were significantly reduced in CCK rats, while neither the number of square crossings nor duration of forward locomotion were significantly modified from controls. With nuclei accumbens septi (NAS) infusions, CCK-8 reduced rearing behavior more than ambulatory behavior in this preliminary testing. With either VTA or NAS infusions, no significant differences from controls were found upon two derived measures of motoric performance, namely, "velocity" (number of squares crossed per second in locomotion) and "vertical stability" (seconds per rear). These results suggest a modulation of dopaminergically-mediated behavior by (sulfated) CCK-8 at the cell body region and terminal fields of the mesolimbic (A10) dopamine system.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6318205     DOI: 10.1016/0196-9781(83)90031-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  5 in total

1.  Differential effects of proglumide on mesolimbic and nigrostriatal dopamine function.

Authors:  J G Csernansky; S Glick; J Mellentin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  CCK-8 injected into the nucleus accumbens attenuates the supersensitive locomotor response to apomorphine in 6-OHDA and chronic-neuroleptic treated rats.

Authors:  F Weiss; A Ettenberg; G F Koob
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

3.  Neurotensin and cholecystokinin coexistence within neurons of the ventral mesencephalon: projections to forebrain.

Authors:  K B Seroogy; A Mehta; J H Fallon
Journal:  Exp Brain Res       Date:  1987       Impact factor: 1.972

4.  Cholecystokinin and tyrosine hydroxylase messenger RNAs in neurons of rat mesencephalon: peptide/monoamine coexistence studies using in situ hybridization combined with immunocytochemistry.

Authors:  K Seroogy; M Schalling; S Brené; A Dagerlind; S Y Chai; T Hökfelt; H Persson; M Brownstein; R Huan; J Dixon
Journal:  Exp Brain Res       Date:  1989       Impact factor: 1.972

5.  Facilitation and inhibition of feeding by a single dose of amphetamine: relationship to baseline intake and accumbens cholecystokinin.

Authors:  T L Sills; F J Vaccarino
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.